Filed a patent for "2-fluorodeschloroketamine for treatment of depression, including treatment-resistant depression" on Tue, April 16, 2024
Filed a patent for "5-mapb or 6-apb for use in drug-assisted psychotherapy" on Fri, April 5, 2024
